Journal of Clinical Oncology and Cancer Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Mini Review - Journal of Clinical Oncology and Cancer Research (2023) Volume 6, Issue 2

Radiation therapy for gynecological cancers: Considerations and approaches.

Emanual Jo*

Department of Internal Medicine, University College of Human Medicine, Michigan, US

*Corresponding Author:
Emanual Jo
Department of Internal Medicine
University College of Human Medicine
Michigan, US
E-mail: Jo@gmail.com

Received: 05-Apr-2023, Manuscript No.AACOCR-23-98728; Editor assigned: 08-Apr-2023, PreQC No.AACOCR-22-98728 (PQ); Reviewed: 22-Apr-2023, QC No.AACOCR-23-98728; Revised: 24-Apr-2023, Manuscript No.AACOCR-23-98728 (R); Published: 28-Apr-2023, DOI:10.35841/aacocr-6.2.145

Citation: Jo E. Radiation therapy for gynecological cancers: Considerations and approaches. J Clin Oncol Cancer Res. 2023;6(2):145

Visit for more related articles at Journal of Clinical Oncology and Cancer Research

Introduction

Radiation therapy is a common treatment option for gynecological cancers, which include cervical, endometrial, and ovarian cancers. Gynecological cancers affect the reproductive organs in women and can be challenging to treat. Radiation therapy is often used in combination with surgery or chemotherapy to achieve the best possible outcomes for patients. In this article, we will discuss the use of radiation therapy for gynecological cancers, including its benefits, limitations, and potential side effects Cervical cancer is the most common gynecological cancer, and radiation therapy plays an important role in its treatment. Radiation therapy may be used as the primary treatment or as adjuvant therapy after surgery or chemotherapy. The two main types of radiation therapy used for cervical cancer are External Beam Radiation Therapy (EBRT) and brachytherapy.

EBRT involves the use of a machine to deliver radiation from outside the body to the cancerous area. The radiation is carefully targeted to minimize damage to healthy tissues. EBRT is typically given five days a week for several weeks, and each treatment session only lasts a few minutes [1].

Brachytherapy involves the insertion of a radioactive source into the vagina or uterus to deliver a high dose of radiation directly to the cancerous area. This type of radiation therapy is usually given after EBRT to further boost the radiation dose to the cancer Endometrial cancer is the most common type of uterine cancer, and radiation therapy is often used in combination with surgery to treat it. The use of radiation therapy in endometrial cancer is dependent on the stage and type of cancer. For early-stage endometrial cancer, radiation therapy may be used as an alternative to surgery in certain situations. For advanced stage endometrial cancer, radiation therapy is typically used as adjuvant therapy after surgery to destroy any remaining cancer cells.

The two main types of radiation therapy used for endometrial cancer are EBRT and brachytherapy. The use of brachytherapy is more common in endometrial cancer than in cervical cancer because the cancer is located in the uterus, making it more accessible for this type of treatment. Ovarian cancer is less common than cervical and endometrial cancer, but it is often more aggressive and difficult to treat. Radiation therapy is not typically used as the primary treatment for ovarian cancer, but it may be used as a palliative treatment to relieve symptoms in advanced cases [2].

Radiation therapy for ovarian cancer involves the use of EBRT to deliver radiation to the pelvis. The radiation may be given alone or in combination with chemotherapy. The use of radiation therapy in ovarian cancer is limited because the ovaries are located deep within the pelvis, making it difficult to target the radiation to the cancerous area without damaging healthy tissues Radiation therapy offers several benefits in the treatment of gynecological cancers. It is a highly targeted treatment that can deliver a high dose of radiation to the cancerous area while minimizing damage to healthy tissues. Radiation therapy can also be used in combination with other treatments, such as surgery and chemotherapy, to achieve the best possible outcomes for patients.

Radiation therapy is particularly effective in cervical and endometrial cancers, where it can be used as the primary treatment or as adjuvant therapy after surgery. In these cases, radiation therapy can significantly reduce the risk of cancer recurrence and improve survival rates. Brachytherapy involves placing a radioactive source inside the tumor or the area surrounding the tumor. It is a highly targeted form of radiation therapy that allows for a higher dose of radiation to be delivered directly to the cancerous area, while sparing the healthy surrounding tissue. Brachytherapy can be used alone or in combination with EBRT for gynecological cancers [3].

There are two types of brachytherapy High-Dose Rate (HDR) and Low-Dose Rate (LDR). HDR brachytherapy involves delivering a high dose of radiation over a short period of time, usually a few minutes. LDR brachytherapy involves delivering a low dose of radiation over a longer period of time, usually several days.Brachytherapy is commonly used to treat cervical and endometrial cancer. In cervical cancer, the radioactive source is inserted into the cervix, either temporarily or permanently. This approach is called intracavitary brachytherapy. In endometrial cancer, the radioactive source is inserted directly into the uterus, either temporarily or permanently. This approach is called intracavitary or interstitial brachytherapy [4].

Benchmarks and RT credentialing vehicles are overseen and applied in a gathering straightforward way by IROC, in this way accessible to all examiners and conventions in every one of the five helpful gatherings. There is no overt repetitiveness in the work and organizations to not have to finish different benchmarks for individual gathering support. A benchmark in picture direction for use by all NCTN individuals is likewise accessible. Despite the fact that picture directed changes are made every day at organizations pre-treatment, the benchmark assesses the course of change when the arranged field isn't adjusted to fundamental pre-treatment imaging [5].

References

  1. Katz A. Interventions for sexuality after pelvic radiation therapy and gynecological cancer. Cancer J. 2009;15(1):45-7.

    2. Indexed at, Google Scholar, Cross Ref

  2. Mayr NA, Huang Z, Sohn JW, et al. Emerging application of stereotactic body radiation therapy for gynecologic malignancies. Expert Rev Anticancer Ther. 2011;11(7):1071-7.

    3. Indexed at, Google Scholar, Cross Ref

  3. Mirabeau-Beale KL, Viswanathan AN. Quality of life (QOL) in women treated for gynecologic malignancies with radiation therapy: a literature review of patient-reported outcomes. Gynecolo Oncol. 2014;134(2):403-9.

    4. Indexed at, Google Scholar, Cross Ref

  4. Gemignani ML, Alektiar KM, Leitao M, et al. Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int J Radiat Oncol Biol Phys. 2001;50(3):687-94.

    5. Indexed at, Google Scholar, Cross Ref

  5. Rades D, Kopelke S, Soror T, et al. Sleep disorders prior to adjuvant radiation therapy for gynecological malignancies. Anticancer Res. 2021;41(9):4407-10.

    6. Indexed at, Google Scholar, Cross Ref

Get the App